Speaking of the "Devil": Diagnostic Errors in Interstitial Lung Diseases
- PMID: 38003904
- PMCID: PMC10672616
- DOI: 10.3390/jpm13111589
Speaking of the "Devil": Diagnostic Errors in Interstitial Lung Diseases
Abstract
Interstitial lung diseases are respiratory diseases, which affect the normal lung parenchyma and can lead to significant pulmonary fibrosis, chronic respiratory failure, pulmonary hypertension, and ultimately death. Reuniting more than 200 entities, interstitial lung diseases pose a significant challenge to the clinician, as they represent rare diseases with vague and insidious respiratory symptoms. As such, there are many diagnostic errors that can appear along the journey of the patient with ILD, which leads to significant delays with implications for the prognosis and the quality of life of the patient.
Keywords: diagnostic delay; diagnostic errors; interstitial lung disease; pulmonary fibrosis.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Association between acute exacerbation and progressive pulmonary fibrosis in interstitial lung disease: a retrospective cohort study.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241276800. doi: 10.1177/17534666241276800. Ther Adv Respir Dis. 2024. PMID: 39235441 Free PMC article.
-
Interstitial Lung Disease: A Review.JAMA. 2024 May 21;331(19):1655-1665. doi: 10.1001/jama.2024.3669. JAMA. 2024. PMID: 38648021 Review.
-
Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.BMC Pulm Med. 2023 Jun 2;23(1):191. doi: 10.1186/s12890-022-02255-w. BMC Pulm Med. 2023. PMID: 37264374 Free PMC article.
-
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities.Lancet Respir Med. 2021 Sep;9(9):1065-1076. doi: 10.1016/S2213-2600(21)00017-5. Epub 2021 Jul 28. Lancet Respir Med. 2021. PMID: 34331867 Review.
-
Diagnostic test interpretation and referral delay in patients with interstitial lung disease.Respir Res. 2019 Nov 12;20(1):253. doi: 10.1186/s12931-019-1228-2. Respir Res. 2019. PMID: 31718645 Free PMC article.
Cited by
-
Chest radiography in interstitial lung disease: Accuracy and radiological features from a systematic review and meta-analysis.Sarcoidosis Vasc Diffuse Lung Dis. 2025 Jun 25;42(2):16108. doi: 10.36141/svdld.v42i2.16108. Sarcoidosis Vasc Diffuse Lung Dis. 2025. PMID: 40699492 Free PMC article.
-
Navigating Drug-Induced Lung Disease (DILD): A Comprehensive Review on Management and Prevention Strategies.Cureus. 2024 Sep 22;16(9):e69954. doi: 10.7759/cureus.69954. eCollection 2024 Sep. Cureus. 2024. PMID: 39445304 Free PMC article. Review.
-
Assessing the global burden of interstitial lung disease and pulmonary sarcoidosis using multiple statistical models: analysis and future projections.BMC Pulm Med. 2025 Jul 24;25(1):352. doi: 10.1186/s12890-025-03813-8. BMC Pulm Med. 2025. PMID: 40707937 Free PMC article.
References
-
- Cottin V., Hirani N.A., Hotchkin D.L., Nambiar A.M., Ogura T., Otaola M., Skowasch D., Park J.S., Poonyagariyagirn H.K., Wuyts W., et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur. Respir. Rev. 2018;27:180076. doi: 10.1183/16000617.0076-2018. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials